Call us directly: 1-408-829-6486

Medstreaming Portal - Login

Privacy Policy and Society of Vascular Surgery statement regarding screenings


SmartHealth respects each individual’s right to personal privacy. We will collect and use information through our website only in the ways disclosed in this statement. At the time of your screening appointment, you can request to receive a copy of our Notice of Privacy Practices containing information on our non-web based privacy practices.

Part I. Information Collection

SmartHealth collects information through our website at several points. We collect the following information from clients who sign up for our services: name, address, city, state, and zip code, email address and phone number. If you elect not to submit this information online, you may call (1-408-829-6486) or e-mail and we can assist you in signing up for our services. SmartHealth does not actively market to children, and we never knowingly ask a child under 18 to divulge his/her personal information without a legal guardians consent.

For our participating clients, we collect this information through registration forms, to assist in scheduling a screening at a particular site. This information is collected voluntarily. For our participating clients who are in the process of signing up for our services, we do not employ cookies. A cookie is a small text file that our Web server places on a user’s computer hard drive to be a unique identifier. Regardless, all personal information is stored on a limited access and secure server.

For all visitors to our website, we may collect web page visits, usage and navigation activities as they relate to our website. Additionally, our site collects standard information from your browser to include IP address, browser type and language, and access times.

Part II. Information Usage

The information collected by SmartHealth will be used for registration and service delivery at our screening events. Users who provide information will receive email confirmations of scheduling, receipts associated with purchase, and email reminders as their scheduled screening date approaches. Registered users may also receive additional announcements from us about products, services, special offers, or a newsletter.

The information we collect may be used to create customer profiles based on browsing or purchasing history. We will not supplement information collected at our website with data from other web-related sources.

We may share data with some third parties to obtain payment for services, to conduct our normal business operations, or in case of emergency in order to obtain treatment for you. We will also share information as required by law. If you approve, we may also use your information to make you aware of other services or benefits that may be of interest to you. You will have an opportunity at the time of your screening to elect to have your information shared with third parties for this purpose.
We offer links to other websites. Please note: When you click on links to other websites, we encourage you to read their privacy policies. Their standards may differ from ours.

Part III. Access to Information

SmartHealth maintains the accuracy of our website information by comparing it to additional health screen information collected at the screening site. Users may access their own personal information and contact us about inaccuracies they may find.

Part IV. Problem Resolution

If problems arise, users may contact SmartHealth at our address listed on our website, through our information email address, or by calling us. We are committed to resolving disputes within an appropriate time frame.

Part V. Data Storage and Security

SmartHealth protects user information with the following security measures: SmartHealth maintains secure servers, extensive firewalls, SSL encryption, and redundant secure back-ups.

Part VI. Changes to the Privacy Policy

SmartHealth reserves the right to amend the terms of its Privacy Policy. If our policy on information collection or usage changes, we will advise you by updating our main web page, to help users understand these changes.

Part VII. Society of Vascular Surgery SVS Position Statement on Vascular Screening

Vascular disease is among the leading causes of death in the United States, yet is generally asymptomatic until a catastrophic event occurs, such as a stroke or aneurysm rupture. Although preventive screening is available, millions of Americans at risk for stroke or death from vascular disorders remain unaware of their risk.

Vascular disease can cause potentially lethal aneurysms of the aorta (AAA), the main artery of the body.

Overall, the probability of AAA in the general population is low, but is increased when certain risk factors are present. These include increasing age, male gender, white race, smoking, family history of aneurysms, history of other vascular aneurysms, hypertension, atherosclerotic diseases, cerebrovascular disease, and high cholesterol.

One-time ultrasound screening for AAA is recommended for all men at or older than 65 years. Screening men as early as 55 years is appropriate for those with a family history of AAA
One-time ultrasound screening for AAA is recommended for all women at or older than 65 years with a family history of AAA or who have smoked
Re-screening patients for AAA is not recommended if an initial ultrasound scan performed on patients 65 years of age or older demonstrates an aortic diameter of Vascular disease can block the carotid arteries to the brain and cause paralyzing strokes.

Stroke is the fourth leading cause of death in the United States1. Each year, 137,000 people die annually from this disorder 1. A large proportion of strokes are caused by plaque in the carotid arteries. In 2010, it was estimated that Americans would pay about US$73.7 billion for stroke-related medical costs and disability2.

Vascular disease can impair circulation to the legs, leading to reduced ability to walk and in some cases, leg amputation. Vascular disease in the legs is a major marker for heart disease.

One in every 20 Americans over the age of 50 has peripheral arterial disease (PAD). It affects eight to 12 million people in the United States. Individuals with PAD suffer a five-fold increased relative risk of a cardiovascular ischemic event and total mortality that is two-three folds greater than those without PAD. Therefore, screening for PAD not only identifies patients with asymptomatic PAD in whom risk factor modification can slow or stop the progression of the disease process, but also allows identification of individuals who may also may be at risk for heart attack and stroke due to blockages affecting these organ systems.

Individuals 55 years of age or older with cardiovascular risk factors such as a history of hypertension, diabetes mellitus, smoking, hypercholesterolemia, or known cardiovascular disease may benefit from preventive screening for vascular disease. Noninvasive screening examinations have proven to be accurate in detecting vascular disease prior to active warning signs and before a major medical incident such as stoke, or sudden death from aneurysm rupture. Appropriate screening examinations in high-risk individuals include:

Ultrasound scan of the aorta to identify aortic aneurysms
Ultrasound scan of the carotid arteries to assess stroke risk
Blood pressure measurements in the legs to identify PAD and risk of heart disease
With the baby boomer population aging and Americans 60-years-old expected to reach nearly 76 million by 20205, raising public awareness about vascular disease and screening becomes critical. The Society for Vascular Surgery believes vascular disease must become a national health care priority and is committed to improving public awareness and understanding of vascular disease.

National Vital Statistics Report, 2010
American Stroke Association, 2010
United States National Institutes of Health, 2010
United States Census Bureau, Interim State Population Projections, 2005

Approved by SVS Board of Directors, January 2011